Two new FDA pilot programs aimed at speeding the drug review process were announced by FDA Commissioner Scot Gottlieb at the 2018 annual meeting of the American Society of Clinical Oncology.
Read the details about these new initiatives, which seek to make improvements to the methods the FDA uses to evaluate new applications during the clinical portion of drug reviews, in this insightful look at what’s to come in bringing new innovations to market, faster.
Read the details about these new initiatives, which seek to make improvements to the methods the FDA uses to evaluate new applications during the clinical portion of drug reviews, in this insightful look at what’s to come in bringing new innovations to market, faster.
